X0708 D LIVE 0001649989 Outlook Therapeutics, Inc. 111 S. WOOD AVENUE UNIT #100 ISELIN NJ NEW JERSEY 08830 6096193990 DELAWARE Oncobiologics, Inc. Corporation true Randy H. Thurman c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Yezan Haddadin c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Kurt J. Hilzinger c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Lawrence A. Kenyon c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Executive Officer Director Faisal G. Sukhtian c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Andong Huang c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Gerd Auffarth c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Julian Gangolli c/o Outlook Therapeutics, Inc. 111 South Wood Avenue, Unit #100 Iselin NJ NEW JERSEY 08830 Director Biotechnology Decline to Disclose 06b false 2026-04-23 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 IL ILLINOIS NY NEW YORK false 5000000 0 5000000 The total offering amount above represents the amount, if any, that the Issuer could receive if all of the issued Warrants were exercised. As of the date of this filing, none of the warrants have been exercised. false 2 0 485000 0 false Outlook Therapeutics, Inc. /s/ Lawrence Kenyon Lawrence Kenyon Interim Chief Executive Officer, CFO, Treas & Sec'y 2026-05-07